Overview

Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the tolerability and safety and to determine whether FXFM244 Antibiotic Foam is effective in the treatment of Acne Vulgaris.
Phase:
Phase 2
Details
Lead Sponsor:
Foamix Ltd.
Vyne Therapeutics Inc.
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Minocycline